In the first-ever clinical trial of the fourth generation of electronic cigarettes, researchers discovered that those who switched to electronic cigarettes were less likely to be exposed to a carcinogen that was a major factor compared to those who continued to smoke combustible cigarettes.
Providence, R.I. [Brown UniversitySmoking cigarettes is responsible for over 480,000 deaths per annually in the United States, according to federal government statistics — and certain smokers find it impossible to stop. Most of them smoke regular, or combustible cigarettes.
Researchers and physicians have long ago explored the advantages and disadvantages of Nicotine-based alternatives to smoking cigarettes New research provides convincing evidence of “pod” e-cigarettes are less harmful to your health than traditional cigarettes.
“Nicotine is one of the most addictive substances on earth, both in animal models as well as in humans,” said Dr. Jasjit S. Ahluwalia Professor of behavioral and social sciences, as well as medical sciences in the department of medicine and behavioral sciences at Brown University. “So how can we assist those who are unable to stop smoking cigarettes that burn? They require alternatives which include e-cigarettes, and they could be one option. Our research suggests that in the short term electronic cigarettes are significantly safer than combustible cigarettes.”
Ahluwalia is the senior author of a brand new JAMA Network Open study, released on Wednesday, November. 18 on the first clinical trial of the fourth generation pod electronic cigarettes.
The study involved the participation of 186 African American and Latinx smokers since the ethnic minorities and racial groups are more likely to suffer higher rates of death and morbidity due to tobacco regardless of whether smokers smoke at the same rate that other populations. The majority of participants received e-cigarettes for six weeks. The remaining participants were advised to smoke combustible cigarettes in the normal way.
After the research, the participants who switched to electronic cigarettes had significantly lower amounts of powerful carcinogen in the lungs NNAL in comparison to those who continued to smoke combustible cigarettes only. E-cigarette smokers also had significantly lower CO (CO) amounts and experienced having fewer respiratory complaints. The benefits of this — less NNAL CO levels, reduced CO levels, and improvement in respiratory symptoms– were especially evident among those who completely switched to electronic cigarettes.
The researchers also assessed participants their levels of cotinine the breakdown product of nicotine and concluded that there were no statistically significant variations between groups, which is which suggests that electronic cigarettes are the necessary replacement for nicotine.
“Anyone under 21 should not take up cigarettes, e-cigarettes, or any nicotine product — hands down, the best thing to do is to never start — but if people use tobacco products, they should quit,” Ahluwalia advised. “But if they cannot quit smoking combustible cigarettes, they should consider using novel nicotine products to either quit smoking altogether or to reduce their harm by transitioning fully to these products.”
Moving forward, research is required to learn more about the risks that are not cancer-related by e-cigarettes, like heart and respiratory disease. Researchers also plan to conduct year-long studies to further investigate the potential harm-reduction benefits of electronic cigarettes.
“Most smokers who switched exclusively from combustible cigarettes to e-cigarettes during the study maintained this behavior at six months, but we need longer-term follow-up,” said Kim Pulvers, a professor of psychology at California State University San Marcos who was the lead participant in the study. “We also need continued study of dual users to determine whether they maintain harm reduction over time.”
Ahluwalia explained that as a large number of people who smoke electronic cigarettes and combustible cigarettes are likely to return to purely smoking combustible cigarettes in the future There is a pressing need for intervention that assists those who attempt to switch to electronic cigarettes but do not succeed. He also stressed the importance of alternative methods to simply quitting completely due to the challenges quitting presents for many smokers.
“Nicotine e-cigarettes and other harm-reduction products may be game-changers for our field,” Ahluwalia said. “I hope that this study inspires more people to conduct this kind of study and to keep an open mind on this. I also hope it will inspire people to let science guide the policy, not emotions.”
Alongside Ahluwalia and Pulvers Other participants are Christopher H. Schmid and Kexin Qu from Brown; Nicole L. Nollen from the University of Kansas School of Medicine as well as Professor. Neal Benowitz from the University of California, San Francisco as well as Myra Rice from California State University San Marcos.
Schmid worked as an expert consultant to legal companies representing Eli Lilly, Boehringer-Ingelheim, and Gilead outside of the study. Benowitz was paid personal fees by Pfizer as well as Achieve Life Sciences and served as a consultant for pharmaceutical companies selling smoking cessation drugs and also for expert witness cases against tobacco companies that were not part of the study. Dr. Ahluwalia was paid personal fees of Lucy Goods outside the study. The details of these payments were disclosed within the research.
The research was supported with the help of the National Institutes of Health (5SC3GM122628) and was additionally supported by the NIH-funded Center of Biomedical Research Excellence (P20GM130414) as well as the National Institute of General Medical Sciences of the NIH (U54GM115677).